Krsnaa Diagnostics Limited is engaged in the business of providing diagnostic services primarily in relation to pathology investigation, radiology investigation, and tele reporting. The Company’s services include pathology, X-Ray and computed tomography (CT) scans, magnetic resonance imaging (MRI), ultrasonography (USG), tele-radiology, tele-pathology, and other diagnostic services. Its laboratory services span a diverse range of investigations, ranging from CBC or blood glucose to highly specialized tests. Its tele-radiology services enable radiologists to offer treatment remotely. Tele-radiology involves transmitting radiological images, such as CT scans, digitized X-rays, MRIs, and ultrasounds between different locations. It offers Ayaksham package, which includes from basic to total plus health checkups. It provides diagnostic testing packages for diabetes, heart health, liver health, kidney health, thyroid, fatigue, cancer, senior citizen care, bone health, and others.As of 10 Jun 2026, Krsnaa Diagnostics share price is ₹544.35. The stock opened at ₹534.20, compared to its previous close of ₹535.50. During today's trading session, Krsnaa Diagnostics share price moved in the range of ₹534.20 to ₹555.10, with an average price of ₹544.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹534.20 and a high of ₹555.10. On the performance front, Krsnaa Diagnostics share price has declined by 26.12% over the last six months and is down 20.72% on a year-on-year basis.
The market capitalization of Krsnaa Diagnostics is ₹1,737 Crs, with a P/E ratio of 17.1 and a dividend yield of 0.00%.